In order to understand the relevance of oncogenic RAS and its dependence on its major downstream effectors, RAF and PI3K, we used a previously described doxycycline (dox)-inducible shRNA system [29] to study the effects of RAS knockdown on cellular proliferation and tumor growth. This evidence concerns the gene RAF1 and neoplasm.